MARKET

JAZZ

JAZZ

Jazz Pharmaceuticals Plc
NASDAQ
129.44
-1.59
-1.21%
Closed 18:06 09/29 EDT
OPEN
131.54
PREV CLOSE
131.03
HIGH
131.80
LOW
129.25
VOLUME
473.31K
TURNOVER
--
52 WEEK HIGH
160.96
52 WEEK LOW
120.64
MARKET CAP
8.17B
P/E (TTM)
-73.1713
1D
5D
1M
3M
1Y
5Y
5 Genius Safe Stocks to Buy for the 4th Quarter of 2023
The Motley Fool · 2h ago
Weekly Report: what happened at JAZZ last week (0925-0929)?
Weekly Report · 2h ago
4 Perfect Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
The Motley Fool · 2d ago
Ionis, AbbVie, Alnylam draw bullish views at Raymond James
Seeking Alpha · 2d ago
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023
Benzinga · 2d ago
Where Jazz Pharmaceuticals Stands With Analysts
Benzinga · 2d ago
Raymond James Initiates Coverage On Jazz Pharmaceuticals with Market Perform Rating
Benzinga · 3d ago
Weekly Report: what happened at JAZZ last week (0918-0922)?
Weekly Report · 09/25 09:03
More
About JAZZ
Jazz Pharmaceuticals PLC is a biotechnology company. The Company is engaged in developing medicines for people with serious diseases. The Company’s lead marketed products include Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution, Xyrem (sodium oxybate) oral solution, Epidiolex (cannabidiol) oral solution, Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn), Zepzelca (lurbinectedin), Defitelio (defibrotide sodium) AND Vyxeos (daunorubicin and cytarabine) liposome for injection. The Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution product is for the treatment of cataplexy or excessive daytime sleepiness (EDS), in patients with narcolepsy seven years of age and older. The Xyrem (sodium oxybate) oral solution product is for the treatment of cataplexy or EDS in patients with narcolepsy seven years of age and older. The Defitelio (defibrotide sodium) product is for the treatment of hepatic veno-occlusive disease (VOD).

Webull offers kinds of Jazz Pharmaceuticals PLC stock information, including NASDAQ:JAZZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JAZZ stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading JAZZ stock methods without spending real money on the virtual paper trading platform.